Other
Pancragen Dosage, Protocol & Research Guide
Dose overview
Every range below is taken from the cited source and carries its evidence grade.
No human dose-finding trial is cited on this page.
Animal data (context only, not a human dose)
Animal figures are shown for context and are never presented as a human dose. Use the converter to see how animal figures scale.
| Source | Species | Dose | Frequency | Route | Duration | Evidence |
|---|---|---|---|---|---|---|
| Goncharova et al., Adv Gerontol 2014 (abstract, Russian)[1]Pancragen (Lys-Glu-Asp-Trp) 50 ug/animal per day for 10 days intramuscularly in old female rhesus monkeys; effect on glucose, insulin and C-peptide response partly remained 3 weeks after discontinuation | rhesus monkey (old females) | 50 mcg[1]intramuscular, amount per animal per day as printed in the abstract; not a human figure | daily for 10 days | intramuscular | — | Animal or in-vitro study |
Evidence grades: A approved label, B human trial, C observational, D animal study, E community-reported.
Reconstitution calculator
Calculator example, not a recommended amount
- Concentration
- 10 mg/mL
- Volume to draw
- 0.025 mL
- Units on a U-100 syringe
- 2.5 units
Properties
- CAS
- Not yet recorded
- Molecular weight
- Not yet recorded
- Formula
- Not yet recorded
- Sequence
- Not yet recorded
- Aliases
- Not yet recorded
- Vial sizes (mg)
- 20
Storage notes
- Lyophilized
- Not yet recorded from a cited source
- Reconstituted stability (days)
- Not yet recorded from a cited source
Side effects, contraindications and regulatory status
Reported side effects
- US patent 7491703 states the peptide was experimentally proved non-toxic but gives no toxicity data on the page; its human example (36 people) gives no adverse-event data. Patent text, not peer-reviewed.[2] Animal study
Report any adverse reaction to a qualified healthcare professional.
What the research says
Summaries of the cited studies, each with its evidence grade.
Goncharova et al., Adv Gerontol 2014 (abstract, Russian)[1]
Goncharova et al., Adv Gerontol 2014 (abstract, Russian): Pancragen (Lys-Glu-Asp-Trp) 50 ug/animal per day for 10 days intramuscularly in old female rhesus monkeys; effect on glucose, insulin and C-peptide response partly remained 3 weeks after discontinuation
Compare vial sizes
| Size | Price | Doses available from the vial Calculated | Cost per dose Calculated |
|---|---|---|---|
| 20 mg | $54.99 | — | — |
Cost per dose uses the listed partner price and the reference dose cited on this page. Prices change; check the product page.
Calculated from a default of 2 mL water (adjustable).
Peptide Protocol Check may earn a commission when you use Pepcore links, at no extra cost to you. Read the disclosure.
Frequently asked questions
Is there a human dose figure for Pancragen on this page?
No human dose figure is cited on this page. The cited research is in animals (evidence grade D); it is shown separately and is not a human dose.
Compound facts
What is the molecular weight of Pancragen?
What is the CAS number of Pancragen?
How is Pancragen stored in the laboratory?
References
Numbered sources used on this page. Markers in the text link here.
- Goncharova et al., Adv Gerontol 2014 (abstract, Russian) pubmed.ncbi.nlm.nih.gov Animal study
- patents.google.com Animal study
Vial sizes and protocols
20 mgPartner size
Available from Pepcore
Supplied as research material for laboratory use only.
- Pancragen Research Material – 20mg 20 mg$54.99Shop at PepcoreCoupon code
LAUNCH20
Peptide Protocol Check may earn a commission when you use Pepcore links, at no extra cost to you. Read the disclosure.